Analysis of the Bayer share price fall and its impact on the Dax

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

According to a report from www.faz.net, the day after the serious 18 percent drop in Bayer shares, shareholders are forced to lick their wounds. The pharmaceutical company's share price fluctuates around the previous day's closing price of 34.27 euros. This price crash also put a strain on the Dax, but yesterday the Dax was only able to close with a minimal loss. Portfolio manager Thomas Altmann comments that Bayer's losses could have been avoided for the sixth day in a row. After the long series of profits, investors are rather cautious and are choosing to wait and see. The Dax gained slightly on this day and remained at 15,932 points. The minutes of the most recent interest rate meeting of...

Gemäß einem Bericht von www.faz.net, Am Tag nach dem schwerwiegenden Kurssturz der Bayer-Aktie um 18 Prozent sind die Aktionäre gezwungen, Wunden zu lecken. Die Aktiennotierung des Pharma-Konzerns schwankt um den Vortagesschlusskurs von 34,27 Euro. Dieser Kursabsturz hat auch den Dax belastet, jedoch konnte der Dax gestern lediglich mit minimalem Verlust schließen. Portfoliomanager Thomas Altmann kommentiert, dass die Bayer-Verluste den sechsten Tag in Folge hätten verhindern können. Die Anleger zeigen sich nach der langen Gewinnserie eher zurückhaltend und gehen zum Abwarten über. Der Dax gewinnt an diesem Tag leicht hinzu und bleibt bei 15.932 Punkten. Die Protokolle der jüngsten Zinssitzung der …
According to a report from www.faz.net, the day after the serious 18 percent drop in Bayer shares, shareholders are forced to lick their wounds. The pharmaceutical company's share price fluctuates around the previous day's closing price of 34.27 euros. This price crash also put a strain on the Dax, but yesterday the Dax was only able to close with a minimal loss. Portfolio manager Thomas Altmann comments that Bayer's losses could have been avoided for the sixth day in a row. After the long series of profits, investors are rather cautious and are choosing to wait and see. The Dax gained slightly on this day and remained at 15,932 points. The minutes of the most recent interest rate meeting of...

Analysis of the Bayer share price fall and its impact on the Dax

According to a report by www.faz.net,

The day after Bayer's share price fell by 18 percent, shareholders are forced to lick their wounds. The pharmaceutical company's share price fluctuates around the previous day's closing price of 34.27 euros. This price crash also put a strain on the Dax, but yesterday the Dax was only able to close with a minimal loss. Portfolio manager Thomas Altmann comments that Bayer's losses could have been avoided for the sixth day in a row. After the long series of profits, investors are rather cautious and are choosing to wait and see. The Dax gained slightly on this day and remained at 15,932 points. The minutes of the Federal Reserve's most recent interest rate meeting are eagerly awaited later in the day.

Morphosys has seen its share price fall by 26 percent due to the results of a study on its promising drug pelabresib. The results lack statistical significance, which has caused the share to lose around half of its value in the past eight trading days.

The financial investor Permira has sold a further 13 million shares in the software provider Teamviewer, reducing its share from almost 21 percent to around 14 percent. The shares were offered for 13.90 euros each and were recently quoted more than 8 percent lower.

Rheinmetall sees its share price rise by 3 percent after announcing new targets for the period up to 2026. Due to increasing defense budgets, sales are expected to increase by an annual average of around 20 percent to 13 to 14 billion euros by 2026.

Evonik's majority shareholder RAG-Stiftung plans to issue convertible bonds with a total nominal value of 500 million euros, which can be exchanged for shares in the specialty chemicals group. At the same time, the foundation wants to buy back outstanding bonds with different maturities in the same amount, which will lead to a fall in the price of Evonik's shares by 2.7 percent.

The above events show that the stock market is influenced by various factors, including company results, insider sales and new targets. These events can have a significant impact on the stock market and the financial industry as investors become more cautious due to uncertainty and may be less inclined to invest.

Read the source article at www.faz.net

To the article